NCT05950139
- Conditions
- ALK Fusion Protein Expression, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Clinical trial condition
Explore clinical trials studying NSCLC Stage IV. Study availability and eligibility vary by location and protocol.
NCT05950139
NCT05543330
NCT06552234
NCT05657873
NCT07279402
NCT07548060
NCT04467723
NCT04136535
NCT06436625